Long-term administration of ranolazine attenuates diastolic dysfunction and adverse myocardial remodeling in a model of heart failure with preserved ejection fraction. (Q53608890)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term administration of ranolazine attenuates diastolic dysfunction and adverse myocardial remodeling in a model of heart failure with preserved ejection fraction. |
scientific article |
Statements
Long-term administration of ranolazine attenuates diastolic dysfunction and adverse myocardial remodeling in a model of heart failure with preserved ejection fraction. (English)
1 reference
Liberato Berrino
1 reference
Antonella De Angelis
1 reference
Donato Cappetta
1 reference
Elena Piegari
1 reference
Barbara Rinaldi
1 reference
Loreta Pia Ciuffreda
1 reference
Grazia Esposito
1 reference
Fiorella Angelica Valeria Ferraiolo
1 reference
Alessia Rivellino
1 reference
Rosa Russo
1 reference
Maria Donniacuo
1 reference
Francesco Rossi
1 reference
12 May 2016
1 reference
217
1 reference
69-79
1 reference
Identifiers
1 reference